PMID: 12411269Nov 2, 2002

Nithsdale Schizophrenia Surveys 23: movement disorders. 20-year review

The British Journal of Psychiatry : the Journal of Mental Science
Jennifer HallidayRobin G McCreadie


In the past 10 years the new atypical antipsychotic drugs have stimulated further interest in the pharmacological management of schizophrenia. The risk of movement disorders has been reported to be less with these new agents. To examine the current prevalence of movement disorders among all people with schizophrenia in a discrete geographical area, to compare the prevalence in patients receiving and not receiving atypical antipsychotic drugs; and to compare current prevalence with prevalence over the past 20 years. In Nithsdale, south-west Scotland, in 1999/2000, we replicated previous studies by using the Abnormal Involuntary Movements Scale, Simpson-Angus scale and Barnes Akathisia Rating Scale to measure tardive dyskinesia, parkinsonism and akathisia, respectively. Mental state was assessed by the Positive and Negative Syndrome Scale. In 136 patients the prevalence of probable tardive dyskinesia was 43%, of parkinsonism 35% and of akathisia 15%. Parkinsonism was present as often in those receiving atypicals as in those receiving standard oral antipsychotics. The prevalence of tardive dyskinesia has doubled over 20 years. Movement disorders remain significant problems for patients despite the introduction of atypical antipsyc...Continue Reading


Jun 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·Robin G McCreadieD H Wiles
Jan 1, 1992·Schizophrenia Bulletin·R Yassa, Dilip V Jeste
Apr 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·J A BergenP J Beumont
May 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·T R Barnes
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Jan 1, 1970·Acta Psychiatrica Scandinavica. Supplementum·G M Simpson, J W Angus
Apr 1, 1982·Archives of General Psychiatry·N R Schooler, J M Kane
Jun 1, 1982·The British Journal of Psychiatry : the Journal of Mental Science·Robin G McCreadieG S Winslow
Jun 1, 1982·The British Journal of Psychiatry : the Journal of Mental Science·Robin G McCreadie
Dec 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·P F LiddleD Kibel
Apr 18, 1998·The American Journal of Psychiatry·Peter N van HartenR S Kahn
Nov 26, 1998·The British Journal of Psychiatry : the Journal of Mental Science·C KellyS Carey
Jul 11, 2000·Acta Psychiatrica Scandinavica. Supplementum·A Leung, P Chue


Apr 15, 2009·Current Treatment Options in Neurology·Frandy Susatia, Hubert H Fernandez
Jul 20, 2007·Schizophrenia Bulletin·R A RosenheckMichael Sernyak
Sep 22, 2005·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Peter Herriot, Kamran Kheirani
Mar 13, 2012·Behavioral and Brain Functions : BBF·Pierre J BlanchetDaniel Lévesque
Sep 8, 2010·The Journal of Clinical Psychiatry·Stanley N CaroffCATIE Investigators
Mar 21, 2007·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Mark B DetweilerKye Y Kim
Nov 30, 2011·International Journal of Psychiatry in Clinical Practice·Mark Richard HarrisonTimothy Dickinson
Nov 5, 2010·International Review of Psychiatry·Shubulade Smith
Apr 1, 2007·Expert Review of Pharmacoeconomics & Outcomes Research·R A RosenheckJeffrey Lieberman
Nov 26, 2009·Expert Opinion on Pharmacotherapy·Alfonso Fasano, Anna Rita Bentivoglio
Jun 4, 2008·Expert Opinion on Pharmacotherapy·Praveen Dayalu, Kelvin L Chou
Mar 18, 2008·Oral and Maxillofacial Surgery Clinics of North America·Ramesh Balasubramaniam, Saravanan Ram
Dec 7, 2007·Schizophrenia Research·Jiri ModestinPuspa Agarwalla
Sep 27, 2006·Clinics in Geriatric Medicine·Kelvin L Chou, Joseph H Friedman
Nov 25, 2003·Health & Social Care in the Community·Sheena AsthanaPhilip Brigham
Aug 7, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·James T TeoKailash Bhatia
May 13, 2014·Asian Journal of Psychiatry·Rashmin M AchaliaOm Prakash
Feb 12, 2004·Journal of Psychopharmacology·Thomas R E Barnes
Jul 3, 2004·Journal of Clinical Psychopharmacology·Ikwunga WonodiGunvant K Thaker
Nov 12, 2005·Journal of Clinical Psychopharmacology·Swapna VermaSiow Ann Chong
Mar 15, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Daniel Tarsy, Ross J Baldessarini
Sep 4, 2007·The British Journal of Psychiatry : the Journal of Mental Science·R A Rosenheck
Sep 28, 2017·International Journal of Psychiatry in Clinical Practice·Nimisha DesaiEla Vatsala
Jul 23, 2020·G3 : Genes - Genomes - Genetics·Paola Giusti-RodríguezFei Zou
May 1, 2004·Journal of Clinical Psychopharmacology·Charles E DeanSean M Nugent
Aug 10, 2005·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Siow Ann ChongSwapna Verma
Jun 24, 2008·CNS Spectrums·Robert Rosenheck Fusar-Poli

Related Concepts

Dyskinesia, Medication-Induced
Health Surveys
Antipsychotic Effect
Ramsay Hunt Paralysis Syndrome

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

The American Journal of Psychiatry
David E RossMichael Weinborn
European Psychiatry : the Journal of the Association of European Psychiatrists
Sherif Karama, Samarthji Lal
© 2021 Meta ULC. All rights reserved